Replies to post #1772 on BioCorRx Inc. (BICX)

[MU_Redskin1]

I agree ... strong earnings numbers and growth projections will fuel the stock's rise. Apparently somebody thinks the stock is worth between $.59 - $.70 per share !!!

If we pick up a few endorsements and other insurance companies and large companies approve of the service we could move dramatically back to the .59 - .70 range.

GLTA

Red

CEYY Price target 0.59 cents ...Old report (Back in march 9th 2011) that is worth reading again . credit 'BIG DREAM'

http://primeequityresearch.com/wp-content/uploads/Prime_Equity_Report_FreshStartCEYY_Mar9_2011_Initiation.pdf

From the 10Q

NOTE 3– INTANGIBLE ASSETS

On October 28, 2010, the Company acquired an exclusive product license, which included the right to use the Naltrexone Implant and any procedures related to the licensed product. The Company paid a onetime license fee of 7.5% of the total common shares outstanding on the date of the agreement, or 5,672,250 common shares at the market value of $0.70 per share as of the date of the agreement. Total value of the license is recorded as $3,970,575.